Literature DB >> 1951632

Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth.

H Merz1, A Fliedner, K Orscheschek, T Binder, W Sebald, H K Müller-Hermelink, A C Feller.   

Abstract

The detection of an increasing number of cytokines and the demonstration of autocrine and paracrine mechanisms perpetuating tumor growth prompted the investigation of the expression of the cytokines IL-2, IL-3, IL-4, IL-5, IL-6, IFN gamma, Tac, and GMCSF in primary lymph-node biopsies of patients with peripheral T-cell lymphoma (n = 11), Hodgkin's disease (n = 13), and large-cell anaplastic lymphoma (n = 6) by means of Northern blot analysis and in situ hybridization (ISH); 15 of 28 cases had IL-6 message, predominantly in cases of Hodgkin's disease (HD) and large-cell anaplastic lymphomas (LCAL). Interferon gamma was found in about 50% of the cases among all entities. Other cytokine expression was rare except two cases of HD with high amounts of IL-4 mRNA. These results indicate that large amounts of growth factor transcripts are present in a variety of malignant lymphomas. The meaning of this expression is still unclear. It may be a loss of physiologic regulation within the cytokine network which may thus influence neoplastic cell growth as some cases have a quantity of cytokine expression which is similar or even above that of stimulated T cells. ISH demonstrates in individual cases that the expression is at least in part due to malignant cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1951632      PMCID: PMC1886335     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

1.  Cytokine expression in B-cell non-Hodgkin lymphomas.

Authors:  H Merz; A Fliedner; T Lehrnbecher; W Sebald; H K Müller-Hermelink; A C Feller
Journal:  Hematol Oncol       Date:  1990 Nov-Dec       Impact factor: 5.271

2.  Immunoglobulin gene rearrangements in Hodgkin's disease.

Authors:  L M Weiss; J G Strickler; E Hu; R A Warnke; J Sklar
Journal:  Hum Pathol       Date:  1986-10       Impact factor: 3.466

3.  Identification of two distinct regulatory regions adjacent to the human beta-interferon gene.

Authors:  K Zinn; D DiMaio; T Maniatis
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

4.  Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities.

Authors:  T Yokota; T Otsuka; T Mosmann; J Banchereau; T DeFrance; D Blanchard; J E De Vries; F Lee; K Arai
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  Molecular cloning and expression of cDNAs for the human interleukin-2 receptor.

Authors:  W J Leonard; J M Depper; G R Crabtree; S Rudikoff; J Pumphrey; R J Robb; M Krönke; P B Svetlik; N J Peffer; T A Waldmann
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

6.  Immunoglobulin and T-cell receptor beta-chain gene rearrangement analysis of Hodgkin's disease: implications for lineage determination and differential diagnosis.

Authors:  D M Knowles; A Neri; P G Pelicci; J S Burke; A Wu; C D Winberg; K Sheibani; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

7.  Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins.

Authors:  G G Wong; J S Witek; P A Temple; K M Wilkens; A C Leary; D P Luxenberg; S S Jones; E L Brown; R M Kay; E C Orr
Journal:  Science       Date:  1985-05-17       Impact factor: 47.728

8.  Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3.

Authors:  Y C Yang; A B Ciarletta; P A Temple; M P Chung; S Kovacic; J S Witek-Giannotti; A C Leary; R Kriz; R E Donahue; G G Wong
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

9.  Structure of the human immune interferon gene.

Authors:  P W Gray; D V Goeddel
Journal:  Nature       Date:  1982-08-26       Impact factor: 49.962

10.  Structure and expression of a cloned cDNA for human interleukin-2.

Authors:  T Taniguchi; H Matsui; T Fujita; C Takaoka; N Kashima; R Yoshimoto; J Hamuro
Journal:  Nature       Date:  1983 Mar 24-30       Impact factor: 49.962

View more
  13 in total

1.  Differential cytokine expression in EBV positive peripheral T cell lymphomas.

Authors:  J W Ho; R H Liang; G Srivastava
Journal:  Mol Pathol       Date:  1999-10

2.  Life stress, mood disturbance, and elevated interleukin-6 in healthy older women.

Authors:  S K Lutgendorf; L Garand; K C Buckwalter; T T Reimer; S Y Hong; D M Lubaroff
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1999-09       Impact factor: 6.053

3.  Pseudoautosomal linkage of Hodgkin disease.

Authors:  M Horwitz; P H Wiernik
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

4.  Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells.

Authors:  Donatella Aldinucci; Dalisa Poletto; Annunziata Gloghini; Paola Nanni; Massimo Degan; Tiziana Perin; Paola Ceolin; Francesca Maria Rossi; Valter Gattei; Antonino Carbone; Antonio Pinto
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

5.  Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.

Authors:  M L Boulland; V Meignin; K Leroy-Viard; C Copie-Bergman; J Brière; R Touitou; P Kanavaros; P Gaulard
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

6.  CD40 expression in Hodgkin's disease.

Authors:  J T O'Grady; S Stewart; J Lowrey; S E Howie; A S Krajewski
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

Review 7.  The role of interleukin-6 in certain age-related diseases.

Authors:  W B Ershler; W H Sun; N Binkley
Journal:  Drugs Aging       Date:  1994-11       Impact factor: 3.923

8.  [Anaplastic large cell lymphoma and keratoacanthoma].

Authors:  M Tronnier; H Merz
Journal:  Hautarzt       Date:  2004-02       Impact factor: 0.751

9.  Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.

Authors:  Q Zhang; I Nowak; E C Vonderheid; A H Rook; M E Kadin; P C Nowell; L M Shaw; M A Wasik
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

Review 10.  Sarcomatoid variant of ALK- anaplastic large cell lymphoma involving multiple lymph nodes and both lungs with production of proinflammatory cytokines: report of a case and review of literature.

Authors:  Lu Yu; Lin Li Yan; Shou Jing Yang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.